Pharmaceutical Excipients Market Size, Share & Industry Analysis, By Type (Organic and Inorganic), By Formulation (OSD, Oral Liquids, Parenteral, Topical & Transdermal, Rectal/Vaginal, and Others), By Functionality (Primary Processing & Performance, Stability & Protection, and Others), By Functionality Application (Stabilizers, Taste Masking, Modified-release, Solubility & Bioavailability Enhancement, and Others), By Source (Plant, Animal, Mineral, Synthetic/Petrochemical, and Others), By End User (Pharma & Biopharma Companies, CMOs/CDMOs, and Others), and Regional Forecast, 2026-2034

Last Updated: April 16, 2026 | Format: PDF | Report ID: FBI115935

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Type Launches, By Key Players
2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
3. Regulatory Scenario, By Key Countries/Regions
4. Overview: Advancements in Pharmaceutical Excipients
Global Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin, HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Southeast Asia
  5. Australia
  6. Rest of Asia Pacific
Latin America Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Types, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Roquette Frères
  2. BASF Pharma Solutions
  3. Evonik Industries AG
  4. Ashland Inc.
  5. Croda Pharma
  6. MEGGLE Excipients
  7. SPI Pharma, Inc.
  8. JRS Pharma GmbH & Co. KG
  9. Shin-Etsu Chemical Co., Ltd.
  10. Colorcon Limited.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Type Launches, By Key Players
2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
3. Regulatory Scenario, By Key Countries/Regions
4. Overview: Advancements in Pharmaceutical Excipients
Global Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin, HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Southeast Asia
  5. Australia
  6. Rest of Asia Pacific
Latin America Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pharmaceutical Excipients Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Organic Chemicals
    1. Carbohydrates & Derivatives
    2. Polymers
    3. Lipids, Fatty Materials & Amphiphiles
    4. Surfactants & Solubilizers
    5. Proteins, Amino Acids & Other Organics
    6. Others
  2. Inorganic Chemicals
    1. Salts & Buffers
    2. Oxides & Hydroxides
    3. Silicates, Aluminosilicates & Clays
    4. Carbonates & Sulfates
    5. Metal-based Specialty Excipients
    6. Others
2. Market Analysis, Insights and Forecast – By Formulation
  1. Oral Solid Dosage (OSD)
    1. Immediate-release tablets (IR)
    2. Modified-release tablets (ER/CR/SR)
    3. Capsules (hard gelatin; HPMC)
    4. ODT / dispersible tablets
    5. Others (OSD)
  2. Oral Liquids
    1. Solutions / syrups
    2. Suspensions
    3. Emulsions
    4. Oral drops
    5. Others (Oral liquids)
  3. Parenteral
    1. Small-volume parenterals (SVP)
    2. Large-volume parenterals (LVP)
    3. Lyophilized injectables
    4. Depot/long-acting injectables
    5. Others (Parenteral)
  4. Topical & Transdermal
    1. Creams
    2. Ointments
    3. Gels
    4. Lotions
    5. Others (Topical & transdermal)
  5. Pulmonary & Nasal
    1. Dry powder inhalers (DPI)
    2. Metered dose inhalers (MDI)
    3. Nebulized solutions
    4. Nasal sprays (solution; suspension)
    5. Others (Pulmonary & nasal)
  6. Ophthalmic & Otic
    1. Ophthalmic solutions
    2. Ophthalmic suspensions
    3. Ophthalmic ointments
    4. Ophthalmic gels / in-situ gels
    5. Others (Ophthalmic & otic)
  7. Rectal / Vaginal
    1. Suppositories / pessaries
    2. Rectal creams/ointments/gels
    3. Vaginal creams/ointments/gels
    4. Vaginal tablets
    5. Others (Rectal/vaginal)
  8. Others
3. Market Analysis, Insights and Forecast – By Functionality
  1. Primary processing & performance roles
  2. Stability & protection roles
  3. Patient experience & adherence roles
  4. Device-compatibility roles
  5. Others
4. Market Analysis, Insights and Forecast – By Functionality Application
  1. Stabilizers
  2. Taste masking
  3. Modified-release
  4. Solubility & bioavailability enhancement
  5. Immediate-release & content uniformity enablement
  6. Injectability & parenteral compatibility
  7. Preservation & microbial control
  8. Other functionality applications
5. Market Analysis, Insights and Forecast – By Source
  1. Plant-derived (botanical)
  2. Animal-derived
  3. Mineral-derived
  4. Synthetic / petrochemical-derived
  5. Others
6. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. CMOs / CDMOs
  3. Research & Academic Institutes
  4. Others
7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Types, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Roquette Frères
  2. BASF Pharma Solutions
  3. Evonik Industries AG
  4. Ashland Inc.
  5. Croda Pharma
  6. MEGGLE Excipients
  7. SPI Pharma, Inc.
  8. JRS Pharma GmbH & Co. KG
  9. Shin-Etsu Chemical Co., Ltd.
  10. Colorcon Limited.

Read Less

List of Figures

Figure 1: Global Pharmaceutical Excipients Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Pharmaceutical Excipients Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Pharmaceutical Excipients Market Value Share (%), by Formulation, 2025 & 2034

Figure 4: Global Pharmaceutical Excipients Market Value Share (%), by Functionality, 2025 & 2034

Figure 5: Global Pharmaceutical Excipients Market Value Share (%), by Functionality Application, 2025 & 2034

Figure 6: Global Pharmaceutical Excipients Market Value Share (%), by Source, 2025 & 2034

Figure 7: Global Pharmaceutical Excipients Market Value Share (%), by End User, 2025 & 2034

Figure 8: Global Pharmaceutical Excipients Market Value Share (%), by Region, 2025 & 2034

Figure 9: North America Pharmaceutical Excipients Market Value (USD billion), by Type, 2025 & 2034

Figure 10: North America Pharmaceutical Excipients Market Value Share (%), by Type, 2025

Figure 11: North America Pharmaceutical Excipients Market Value (USD billion), by Formulation, 2025 & 2034

Figure 12: North America Pharmaceutical Excipients Market Value Share (%), by Formulation, 2025

Figure 13: North America Pharmaceutical Excipients Market Value (USD billion), by Functionality 2025 & 2034

Figure 14: North America Pharmaceutical Excipients Market Value Share (%), by Functionality 2025

Figure 15: North America Pharmaceutical Excipients Market Value (USD billion), by Functionality Application, 2025 & 2034

Figure 16: North America Pharmaceutical Excipients Market Value Share (%), by Functionality Application, 2025

Figure 17: North America Pharmaceutical Excipients Market Value (USD billion), by Source, 2025 & 2034

Figure 18: North America Pharmaceutical Excipients Market Value Share (%), by Source, 2025

Figure 19: North America Pharmaceutical Excipients Market Value (USD billion), by End User, 2025 & 2034

Figure 20: North America Pharmaceutical Excipients Market Value Share (%), by End User, 2025

Figure 21: North America Pharmaceutical Excipients Market Value (USD billion), by Country, 2025 & 2034

Figure 22: North America Pharmaceutical Excipients Market Value Share (%), by Country, 2025

Figure 23: Europe Pharmaceutical Excipients Market Value (USD billion), by Type, 2025 & 2034

Figure 24: Europe Pharmaceutical Excipients Market Value Share (%), by Type, 2025

Figure 25: Europe Pharmaceutical Excipients Market Value (USD billion), by Formulation, 2025 & 2034

Figure 26: Europe Pharmaceutical Excipients Market Value Share (%), by Formulation, 2025

Figure 27: Europe Pharmaceutical Excipients Market Value (USD billion), by Functionality 2025 & 2034

Figure 28: Europe Pharmaceutical Excipients Market Value Share (%), by Functionality 2025

Figure 29: Europe Pharmaceutical Excipients Market Value (USD billion), by Functionality Application, 2025 & 2034

Figure 30: Europe Pharmaceutical Excipients Market Value Share (%), by Functionality Application, 2025

Figure 31: Europe Pharmaceutical Excipients Market Value (USD billion), by Source, 2025 & 2034

Figure 32: Europe Pharmaceutical Excipients Market Value Share (%), by Source, 2025

Figure 33: Europe Pharmaceutical Excipients Market Value (USD billion), by End User, 2025 & 2034

Figure 34: Europe Pharmaceutical Excipients Market Value Share (%), by End User, 2025

Figure 35: Europe Pharmaceutical Excipients Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 36: Europe Pharmaceutical Excipients Market Value Share (%), by Country/ Sub-region, 2025

Figure 37: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by Type, 2025 & 2034

Figure 38: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by Type, 2025

Figure 39: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by Formulation, 2025 & 2034

Figure 40: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by Formulation, 2025

Figure 41: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by Functionality 2025 & 2034

Figure 42: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by Functionality 2025

Figure 43: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by Functionality Application, 2025 & 2034

Figure 44: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by Functionality Application, 2025

Figure 45: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by Source, 2025 & 2034

Figure 46: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by Source, 2025

Figure 47: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by End User, 2025 & 2034

Figure 48: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by End User, 2025

Figure 49: Asia Pacific Pharmaceutical Excipients Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 50: Asia Pacific Pharmaceutical Excipients Market Value Share (%), by Country/ Sub-region, 2025

Figure 51: Latin America Pharmaceutical Excipients Market Value (USD billion), by Type, 2025 & 2034

Figure 52: Latin America Pharmaceutical Excipients Market Value Share (%), by Type, 2025

Figure 53: Latin America Pharmaceutical Excipients Market Value (USD billion), by Formulation, 2025 & 2034

Figure 54: Latin America Pharmaceutical Excipients Market Value Share (%), by Formulation, 2025

Figure 55: Latin America Pharmaceutical Excipients Market Value (USD billion), by Functionality 2025 & 2034

Figure 56: Latin America Pharmaceutical Excipients Market Value Share (%), by Functionality 2025

Figure 57: Latin America Pharmaceutical Excipients Market Value (USD billion), by Functionality Application, 2025 & 2034

Figure 58: Latin America Pharmaceutical Excipients Market Value Share (%), by Functionality Application, 2025

Figure 59: Latin America Pharmaceutical Excipients Market Value (USD billion), by Source, 2025 & 2034

Figure 60: Latin America Pharmaceutical Excipients Market Value Share (%), by Source, 2025

Figure 61: Latin America Pharmaceutical Excipients Market Value (USD billion), by End User, 2025 & 2034

Figure 62: Latin America Pharmaceutical Excipients Market Value Share (%), by End User, 2025

Figure 63: Latin America Pharmaceutical Excipients Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 64: Latin America Pharmaceutical Excipients Market Value Share (%), by Country/ Sub-region, 2025

Figure 65: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by Type, 2025 & 2034

Figure 66: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by Type, 2025

Figure 67: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by Formulation, 2025 & 2034

Figure 68: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by Formulation, 2025

Figure 69: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by Functionality 2025 & 2034

Figure 70: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by Functionality 2025

Figure 71: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by Functionality Application, 2025 & 2034

Figure 72: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by Functionality Application, 2025

Figure 73: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by Source, 2025 & 2034

Figure 74: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by Source, 2025

Figure 75: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by End User, 2025 & 2034

Figure 76: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by End User, 2025

Figure 77: Middle East & Africa Pharmaceutical Excipients Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 78: Middle East & Africa Pharmaceutical Excipients Market Value Share (%), by Country/ Sub-region, 2025

Figure 79: Global Pharmaceutical Excipients Market Share (%), by Company, 2025

List of Tables

Table 1: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 2: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Organic Chemicals, 2021–2034

Table 3: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Inorganic Chemicals, 2021–2034

Table 4: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Formulation, 2021–2034

Table 5: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Solid Dosage (OSD), 2021–2035

Table 6: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Liquids, 2021–2036

Table 7: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Parenteral, 2021–2037

Table 8: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Topical & Transdermal, 2021–2038

Table 9: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Pulmonary & Nasal, 2021–2039

Table 10: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Ophthalmic & Otic, 2021–2040

Table 11: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Rectal / Vaginal, 2021–2041

Table 12: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality 2021–2034

Table 13: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality Application, 2021–2034

Table 14: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 15: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 16: Global Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 17: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 18: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Organic Chemicals, 2021–2034

Table 19: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Inorganic Chemicals, 2021–2034

Table 20: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Formulation, 2021–2034

Table 21: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Solid Dosage (OSD), 2021–2035

Table 22: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Liquids, 2021–2036

Table 23: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Parenteral, 2021–2037

Table 24: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Topical & Transdermal, 2021–2038

Table 25: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Pulmonary & Nasal, 2021–2039

Table 26: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Ophthalmic & Otic, 2021–2040

Table 27: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Rectal / Vaginal, 2021–2041

Table 28: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality 2021–2034

Table 29: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality Application, 2021–2034

Table 30: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 31: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 32: North America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Country, 2021-2034

Table 33: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 34: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Organic Chemicals, 2021–2034

Table 35: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Inorganic Chemicals, 2021–2034

Table 36: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Formulation, 2021–2034

Table 37: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Solid Dosage (OSD), 2021–2035

Table 38: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Liquids, 2021–2036

Table 39: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Parenteral, 2021–2037

Table 40: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Topical & Transdermal, 2021–2038

Table 41: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Pulmonary & Nasal, 2021–2039

Table 42: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Ophthalmic & Otic, 2021–2040

Table 43: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Rectal / Vaginal, 2021–2041

Table 44: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality 2021–2034

Table 45: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality Application, 2021–2034

Table 46: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 47: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 48: Europe Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 49: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 50: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Organic Chemicals, 2021–2034

Table 51: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Inorganic Chemicals, 2021–2034

Table 52: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Formulation, 2021–2034

Table 53: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Solid Dosage (OSD), 2021–2035

Table 54: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Liquids, 2021–2036

Table 55: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Parenteral, 2021–2037

Table 56: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Topical & Transdermal, 2021–2038

Table 57: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Pulmonary & Nasal, 2021–2039

Table 58: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Ophthalmic & Otic, 2021–2040

Table 59: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Rectal / Vaginal, 2021–2041

Table 60: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality 2021–2034

Table 61: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality Application, 2021–2034

Table 62: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 63: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 64: Asia Pacific Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 65: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 66: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Organic Chemicals, 2021–2034

Table 67: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Inorganic Chemicals, 2021–2034

Table 68: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Formulation, 2021–2034

Table 69: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Solid Dosage (OSD), 2021–2035

Table 70: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Liquids, 2021–2036

Table 71: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Parenteral, 2021–2037

Table 72: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Topical & Transdermal, 2021–2038

Table 73: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Pulmonary & Nasal, 2021–2039

Table 74: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Ophthalmic & Otic, 2021–2040

Table 75: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Rectal / Vaginal, 2021–2041

Table 76: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality 2021–2034

Table 77: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality Application, 2021–2034

Table 78: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 79: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 80: Latin America Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

Table 81: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 82: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Organic Chemicals, 2021–2034

Table 83: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Inorganic Chemicals, 2021–2034

Table 84: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Formulation, 2021–2034

Table 85: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Solid Dosage (OSD), 2021–2035

Table 86: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Oral Liquids, 2021–2036

Table 87: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Parenteral, 2021–2037

Table 88: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Topical & Transdermal, 2021–2038

Table 89: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Pulmonary & Nasal, 2021–2039

Table 90: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Ophthalmic & Otic, 2021–2040

Table 91: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Rectal / Vaginal, 2021–2041

Table 92: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality 2021–2034

Table 93: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Functionality Application, 2021–2034

Table 94: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 95: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 96: Middle East & Africa Pharmaceutical Excipients Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 190

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com